| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d5cf72494e3534a88b0bc4f8971c37f3 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5767
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-576 |
| filingDate |
2012-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_926a7d23e0da1cb86e1632814a6e993f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c872155c49cc52f7cd0e069c402ea68c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f0245cea14bc3f9ad7eddaed77e8671f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0dc9f7fe2992d054ac2235210708095d |
| publicationDate |
2014-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-2776590-A1 |
| titleOfInvention |
Prognostic method for checking efficacy of micro rna-122 inhibitors in hcv+ patients |
| abstract |
The present invention relates to the treatment of subjects infected with HCV which have been identified as likely responders to HCV therapy with a miR-122 inhibitor. The invention also provides for prognostic methods for determining the suitability of treatment of hepatitis C infection with an anti-HCV agent such as a miR-122 inhibitor. |
| priorityDate |
2011-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |